Author

B. Moser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. A. Shanbhag· 1 shared A. Cavalli· 1 shared A. Ciurea· 1 shared A. Mantovani· 1 shared A. Manzo· 1 shared A. Rauch· 1 shared A. Voza· 1 shared B. A. Fallon· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. A. Shanbhag

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HybriSeq: Probe-based Device-free Single-cell RNA Profiling

D. Foyt, D. Brown, S. Zhou, B. Moser, Q. Zhu, Z. J. Gartner, B. Huang

HybriSeq enables sensitive single-cell RNA profiling by combining in situ hybridization, split-pool barcoding, and sequencing to detect transcripts without end bias.

bioRxiv · Sep 27, 2023Bioengineering

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course

J. Muri, V. Cecchinato, A. Cavalli, A. A. Shanbhag, M. Matkovic, M. Biggiogero, P. A. Maida, J. Moritz, C. Toscano, E. Ghovehoud, R. Furlan, F. Barbic, A. Voza, G. De Nadai, C. Cervia, , Franzetti-Pelland

The paper finds that anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease outcomes and predict absence of long COVID symptoms.

bioRxiv · May 23, 2022 · PreprintImmunology